Get Started

SVRA

NASD Savara, Inc.
Nov 3, 2026 · 12:45 PM ET DELAYED Market Open

$4.76 ↑ +0.02 (+0.53%) Trading Up from the previous close of $4.73, $0.13 below the day’s high of $4.88

YTD change
-21.14%
vs 20-day SMA
+0.56%
vs 200-day SMA
-11.71%

Price ranges

Previous day
$4.67 $4.91
open $4.83 close $4.73
-$0.10 (-2.07%)
Today
$4.75 $4.88
open $4.78 now $4.76
-$0.03 (-0.52%)
Past week
$4.45 $5.14
from $4.52 now $4.76
+$0.24 (+5.20%)
Past month
$4.13 $5.14
from $4.78 now $4.76
-$0.03 (-0.52%)
This year
$4.13 $6.49
from $6.03 now $4.76
-$1.28 (-21.14%)

Price & Performance

-0.57 (-10.75%) / 6M

$4.05$4.88$5.72$6.55May 4Aug 4Nov 2

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 72.3% away from all-time highs of $17.19
  • SVRA is down 21% since the beginning of the year
  • SVRA is up 11% over the past 12 months
  • SVRA is down 1% over the past 1 month
  • 14% of all SVRA investors are betting against SVRA

SVRA reads neutral: price sits above one of the two key moving averages, the 12-month move is +10.8%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.16
Earnings momentum +2.0% Quarterly EPS growth
Quarterly change +2.0%

Valuation

P/E ratio N/A
Enterprise value $1.1B
Beta -0.31

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$173.0M
Debt$30.4K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $974.4M

Savara, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Its program includes molgramostim, which is an inhaled formulation of recombinant human GM-CSF and being developed for the treatment of autoimmune pulmonary alveolar proteinosis. The company was founded in December 1995 and is headquartered in Langhorne, PA.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,410.99 -0.46%
JNJ Johnson & Johnson $270.56 -0.97%
ABBV AbbVie, Inc. $288.84 -2.05%
MRK Merck & Co., Inc. $148.36 -0.78%
RHHBY Roche Holding Ltd Sponsored ADR $60.67 -0.98%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.